Maus, V., Weber, W., Berlis, A., Maurer, C., & Fischer, S.
Initial Experience with Surpass Evolve Flow Diverter in the Treatment of Intracranial Aneurysms
86%
Favorable occlusion rate (OKM C-D) at 4 months
75%
Complete occlusion rate (OKM D) at 4 months
| Number of patients | 42 |
| Number of aneurysms | 46 |
| Major morbidity and mortality | 2% |
| In-stent stenosis (≥50%) | 3% (1/34) |
Clinical Neuroradiology | 2020
Maus, V., Weber, W., Berlis, A., Maurer, C., & Fischer, S. (2021). Initial Experience with Surpass Evolve Flow Diverter in the Treatment of Intracranial Aneurysms. Clinical neuroradiology, 31(3), 681–689. https://doi.org/10.1007/s00062-020-00972-5
Stryker or its affiliated entities own, use, or have applied for the following trademarks or service marks: Stryker, Surpass Evolve. All other trademarks are trademarks of their respective owners or holders.
Information contained herein for use outside the US only.
AP004698 v1.0